People

Michael J. LaCascia

Partner

LaCascia, Michael J.

Michael LaCascia is a partner in the Corporate Practice Group, the Mergers and Acquisitions Practice Group and the Emerging Company Practice Group. He joined the firm in 1990.

Practice

Mr. LaCascia's practice primarily involves mergers and acquisitions of both publicly traded and private companies, advising financial advisors in connection with mergers and acquisition activities, public offerings of securities (as both issuer's and underwriter's counsel), venture capital work and general corporate work for ongoing clients.

 

Honors & Awards

  • Recognized in the November 2004 edition of Boston Magazine as a "Massachusetts Super Lawyer" in mergers and acquisitions

Publications & News

View

November 5, 2007

WilmerHale Advises EqualLogic in $1.4 Billion Acquisition by Dell

Largest Cash Purchase Price in History for Private VC-Backed Company

March 27, 2007

Kronos Agrees to Acquisition by Hellman & Friedman

Recent Highlights

Mr. LaCascia has represented buyers and sellers in public and private transactions, including the following:

  • Kronos Incorporated’s $1.9 billion sale to Hellman & Friedman
  • Infinity Pharmaceutical’s reverse merger with Discovery Partners
  • Critical Therapeutics’ reverse merger with Cornerstone BioPharma Holdings
  • IDX Systems’ $1.2 billion sale to GE
  • SilverStream Software, Inc.’s $158 million disposition to Novell, Inc.
  • Innoveda, Inc.’s $212 million disposition to Mentor Graphics Corporation
  • PerkinElmer, Inc.’s $600 million acquisition of Packard BioScience Company
  • CMGI, Inc.’s $1.8 billion acquisition of AdForce, Inc.
  • CMGI, Inc.’s $2.5 billion acquisition of Flycast Communications Corp.
  • NMT Medical, Inc.’s $50 million disposition of its vena cava filter business to C.R. Bard, Inc.
  • Spring Tide Networks’ $1.5 billion sale to Lucent Technologies
  • AMI Leasing’s sale to Ford Motor Credit Company
  • EnergyNorth Inc.’s $250 million sale to Eastern Enterprises (Boston Gas)
  • Ocean Spray Cranberries, Inc.’s sale of its Mauna La’i product line
  • Syntonix Pharmaceuticals’ $120 million sale to Biogen Idec
  • Nordica N.V.’s acquisition of Rollerblade, Inc.
  • Infinity Pharmaceuticals in its collaboration with and equity investment by Purdue Pharma
  • Axsun Technologies in its $22 million sale to Volcano Corporation

Professional Activities

  • Lecturer in Law – Boston University School of Law – “Negotiated Mergers & Acquisitions”
  • Co-Chairman – Boston Bar Association Mergers & Acquisitions Committee (2009)

Practices

Skip Navigation Links.

Education

JD, Boston University School of Law, 1990, Editor, Annual Review of Banking Law

AB, cum laude, Harvard University, 1986

Bar Admissions

Massachusetts